In an early study, c‐erb‐B2 (HER2) expression was detected in 34 of 44 (77%) cervical adenocarcinomas, with strong membrane staining in 11 of 44 (25%), which was associated with advanced tumor stage and poor prognosis [17]. This evidence concerns the gene ERBB2 and cervical adenocarcinoma.